Vitafoods Europe 2026: Kerry looks to close clinical gap in women’s health nutrition
29 May 2026 | Kerry
Kerry’s R&D director for women and infant health, Monica Maria Olivarez, talked with us about the company’s clinically validated probiotic and botanical ingredient portfolio that targets fertility, menopause, cognitive stress, and sleep. She highlighted the role of science-driven clinical trials and AI-driven research to help identify and address unmet needs in women’s health.
Subscribe to our newsletters
By continuing to browse our site you agree to our Privacy Statement

















